Read the latest SARC happenings and news archives here. For media inquires and resources, please contact us.
“I’d like to share an abridged view into some of SARC’s present and future research initiatives and strategic planning to evolve SARC’s collaborative model for even greater impact…Among the areas …
Read more
Save the date! The SARC semiannual (virtual) meeting at ASCO, will be held the morning of Friday, June 4th, 9:00 am–noon Eastern Time.
Read more
Sarcoma was highlighted during 2021 Rare Disease Day at the National Institute for Health (NIH). Dr. Francis Collins, NIH Director noted “We’ve made real progress in these 10 years, first …
Read more
Congratulations to Brigitte Widemann, MD, for being named a Top Ten Clinical Research Achievement Awardee by the Clinical Research Forum and receiving a Distinguished Clinical Research Achievement Award for her …
Read more
The Sarcoma Coalition welcomed Nilsa Ramirez, MD, Director of the Biopathology Center at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to discuss patient advocacy considerations related to biospecimen …
Read more
Message (excerpt) from Dr. Okuno to SARC Members: SARC has several “open, active, enrolling clinical trials [including] extremity soft tissue sarcoma trial using radiation therapy and immunotherapy neoadjuvantly…for advanced metastatic …
Read more
SARC037 is a phase I study protocol to determine the recommended dose of trabectedin given as a 1-hour infusion in combination with low dose irinotecan. All patients enrolled will receive trabectedin combination …
Read more
SARC celebrates Denise Reinke as she received the Women Paving the Path Forward Award at the Life Raft Group’s Recognizing Women in Sarcoma Gala. The Women in Sarcoma series highlights …
Read more
SARC is proud to partner with Sara’s Cure and Rafael Pharmaceuticals for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear …
Read more
Open accruing studies for you to refer or enroll your patients: SARC024 for Rhabdomyosarcoma (alveolar and embryonal) and Mesenchymal Chondrosarcoma SARC031 for Unresectable or Metastatic NF1 Associated or Sporadic Malignant Peripheral Nerve …
Read more